181 related articles for article (PubMed ID: 10488423)
1. [Abnormal expression of several oncogenes during hepatocarcinogenesis in WHV/myc transgenic mice].
Liu P; Zhao Z; Dominique B
Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):110-2. PubMed ID: 10488423
[TBL] [Abstract][Full Text] [Related]
2. Hepatocarcinogenesis in woodchuck hepatitis virus/c-myc mice: sustained cell proliferation and biphasic activation of insulin-like growth factor II.
Liu P; Terradillos O; Renard CA; Feldmann G; Buendia MA; Bernuau D
Hepatology; 1997 Apr; 25(4):874-83. PubMed ID: 9096591
[TBL] [Abstract][Full Text] [Related]
3. Coordinate expression of N-myc 2 and insulin-like growth factor II in precancerous altered hepatic foci in woodchuck hepatitis virus carriers.
Yang D; Alt E; Rogler CE
Cancer Res; 1993 May; 53(9):2020-7. PubMed ID: 8481904
[TBL] [Abstract][Full Text] [Related]
4. Liver-specific expression and high oncogenic efficiency of a c-myc transgene activated by woodchuck hepatitis virus insertion.
Etiemble J; Degott C; Renard CA; Fourel G; Shamoon B; Vitvitski-Trépo L; Hsu TY; Tiollais P; Babinet C; Buendia MA
Oncogene; 1994 Mar; 9(3):727-37. PubMed ID: 8108115
[TBL] [Abstract][Full Text] [Related]
5. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
[TBL] [Abstract][Full Text] [Related]
6. Molecular and genetic analysis of liver oncogenesis in transforming growth factor alpha transgenic mice.
Takagi H; Sharp R; Hammermeister C; Goodrow T; Bradley MO; Fausto N; Merlino G
Cancer Res; 1992 Oct; 52(19):5171-7. PubMed ID: 1394122
[TBL] [Abstract][Full Text] [Related]
7. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
[TBL] [Abstract][Full Text] [Related]
8. Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice.
Pasquinelli C; Bhavani K; Chisari FV
Cancer Res; 1992 May; 52(10):2823-9. PubMed ID: 1316229
[TBL] [Abstract][Full Text] [Related]
9. The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice.
Terradillos O; Billet O; Renard CA; Levy R; Molina T; Briand P; Buendia MA
Oncogene; 1997 Jan; 14(4):395-404. PubMed ID: 9053836
[TBL] [Abstract][Full Text] [Related]
10. [Expression of cellular oncogenes during hepatocarcinogenesis in rats].
Li S
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Apr; 12(2):121-5. PubMed ID: 2143111
[TBL] [Abstract][Full Text] [Related]
11. Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade.
Calvisi DF; Factor VM; Loi R; Thorgeirsson SS
Cancer Res; 2001 Mar; 61(5):2085-91. PubMed ID: 11280770
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma in WHV/N-myc2 transgenic mice: oncogenic mutations of beta-catenin and synergistic effect of p53 null alleles.
Renard CA; Fourel G; Bralet MP; Degott C; De La Coste A; Perret C; Tiollais P; Buendia MA
Oncogene; 2000 May; 19(22):2678-86. PubMed ID: 10851067
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of interferon alpha in primary prevention of preneoplastic lesions in a transgenic murine model of hepatocellular carcinoma related to the interaction between woodchuck hepatitis viruses and c-myc oncogene].
Merle P; Levy R; Vitvitski L; Chevallier M; Buendia MA; Trepo C
Gastroenterol Clin Biol; 1997; 21(6-7):459-65. PubMed ID: 9295972
[TBL] [Abstract][Full Text] [Related]
14. Cellular distribution of c-myc transcripts during chemical hepatocarcinogenesis in rats.
Nagy P; Evarts RP; Marsden E; Roach J; Thorgeirsson SS
Cancer Res; 1988 Oct; 48(19):5522-7. PubMed ID: 3416306
[TBL] [Abstract][Full Text] [Related]
15. Ploidy and karyotypic alterations associated with early events in the development of hepatocarcinogenesis in transgenic mice harboring c-myc and transforming growth factor alpha transgenes.
Sargent LM; Sanderson ND; Thorgeirsson SS
Cancer Res; 1996 May; 56(9):2137-42. PubMed ID: 8616862
[TBL] [Abstract][Full Text] [Related]
16. [HBV status and expression of ets-2, IGF-II, C-myc and N-ras in human hepatocellular carcinoma and adjacent nontumorous tissues--a comparative study].
Lian ZR
Zhonghua Zhong Liu Za Zhi; 1991 Jan; 13(1):5-8. PubMed ID: 1653692
[TBL] [Abstract][Full Text] [Related]
17. Oncogene-induced liver neoplasia in transgenic mice.
Sandgren EP; Quaife CJ; Pinkert CA; Palmiter RD; Brinster RL
Oncogene; 1989 Jun; 4(6):715-24. PubMed ID: 2543942
[TBL] [Abstract][Full Text] [Related]
18. Paradoxical inhibition of c-myc-induced carcinogenesis by Bcl-2 in transgenic mice.
de La Coste A; Mignon A; Fabre M; Gilbert E; Porteu A; Van Dyke T; Kahn A; Perret C
Cancer Res; 1999 Oct; 59(19):5017-22. PubMed ID: 10519417
[TBL] [Abstract][Full Text] [Related]
19. Specific expression of cellular oncogenes c-myc and c-myb in T-cell lines established from three types of bovine lymphosarcomas.
Ishiguro N; Matsui T; Shinagawa M
Am J Vet Res; 1993 Dec; 54(12):2010-4. PubMed ID: 8116930
[TBL] [Abstract][Full Text] [Related]
20. Ontogeny of Ha-ras and c-myc mRNA levels in rabbit embryo and extraembryonic tissues by quantitative in situ hybridization.
Martinoli MG; Lambert RD; Pothier F; Pelletier G
Mol Reprod Dev; 1992 Jan; 31(1):1-8. PubMed ID: 1562321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
